Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
TAY TWO CO., LTD., based in West Japan, is a comprehensive second-hand retail company focused on reselling pre-owned goods.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Yasuyoshi Mitsumoto is Board Member at Tay Two Co Ltd.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Forsee Power Aims for €100M: CEO Christophe Gurtner Discusses Smart Batteries and Market Strategy |Christophe Gurtner,CEO , Forsee Power SA.
00:10:00
Inspiring Through Music and Grief: Christy Nockels' Journey | BlueTrust
00:10:00
Urs Jordi to Continue as CEO of Aryzta Until 2024: A Turnaround Success Story | Urs Jordi, CEO, Aryzta Inc.
00:10:00
Unveiling Taiwan's Pivotal Role in Micro-LED Technological Breakthroughs | Dr. Charles Lee, CEO, PlayNitride Inc.
00:10:00
AMSC President and CEO Daniel McGahn discusses the real-life consequences of a failed intellectual property transfer.|Daniel McGahn, Chairman, President, and CEO of American Superconductor
00:10:00
A Message from Air Canada President and CEO, Calin Rovinescu | Calin Rovinescu, CEO, Air Canada.
00:10:00
"Key Considerations: What Capital Partners Seek in Independent Sponsors - Insights from the 2021 Independent Sponsor Conference"
00:10:00
The firm investing in technology and healthcare for betterment|Liza Landsman,General Partner,New Enterprise Associates (NEA)
00:10:00
Unveiling the Future: Cipla's Vision for Expanding Market Reach, Innovating with Semaglutide, and Navigating Regulatory Challenges | Umang Vohra ,CEO, Cipla Ltd.
00:10:00
Tax Reform and Deductions: What You Need to Know | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
Biopharmaceutical company focused on the development and commercialization of firstinclass critical care products|Myron Holubiak,CEO,Citius Pharmaceuticals
00:10:00
The Franco Regime: Legacy and Contemporary Perspectives|Stanley G. Payne,Professor,University of Wisconsin-Madison